A Dose Titration of Droxidopa in Patients With Spinal Cord Injury
A Dose Response Trial of Droxidopa to Treat Hypotension in Persons With SCI
Sponsor: Bronx VA Medical Center
This PHASE1 trial investigates Hypotension and Spinal Cord Injury and is currently completed. Bronx VA Medical Center leads this study, which shows 7 recorded versions since 2011 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
7 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE1
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE1
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE1
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE1
▶ Show 2 earlier versions
-
Feb 2017 — Jun 2018 [monthly]
Completed PHASE1
-
Jan 2017 — Feb 2017 [monthly]
Completed PHASE1
First recorded
May 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Bronx VA Medical Center
- Chelsea Therapeutics
For direct contact, visit the study record on ClinicalTrials.gov .